01:33 PM EDT, 08/12/2026 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) closed the first tranche of a non-brokered private placement, raising C$1.4 million, it said on Wednesday.

The company placed 13.94-million share units priced at C$0.10 apiece and made up of a share and a two-year warrant to buy a share for C$0.20.

The company also increased the size of the offering from C$1.5 million to up to C$2 million and extended the offering by 30 days to Sept. 10.

Proceeds will be used to advance its pipeline, to support advancement of the kt-3000 LNP formulation program, ongoing kt-2000AI compound development, and general working capital needs, it said.

Shares of the company were last seen up C$0.01, or 7.7%, to C$0.14 on the TSX Venture Exchange.

Price: 0.14, Change: +0.01, Percent Change: +7.69